Implante valvular aórtico transarterial: experiencia en Chile
Background: Transcatheter aortic valve implantation (TAVI) is taking a leading role in the management of patients with severe aortic stenosis. Valve replacement surgery prolongs survival and is the technique of choice considering its historical background and long experience worldwide. Recently howe...
Guardado en:
Autores principales: | , , , , , , , , |
---|---|
Lenguaje: | Spanish / Castilian |
Publicado: |
Sociedad Médica de Santiago
2013
|
Materias: | |
Acceso en línea: | http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872013000100001 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:scielo:S0034-98872013000100001 |
---|---|
record_format |
dspace |
spelling |
oai:scielo:S0034-988720130001000012013-05-23Implante valvular aórtico transarterial: experiencia en ChileCaorsi,CarlosBaeza,CristianMorís,CésarOyonarte,MiguelVenegas,Juan CarlosYovanovich,JorgeRufs,JorgeDíaz,RodrigoEspíndola,Manuel Aortic valve replacement Aortic valve stenosis Balloon valvuloplasty Background: Transcatheter aortic valve implantation (TAVI) is taking a leading role in the management of patients with severe aortic stenosis. Valve replacement surgery prolongs survival and is the technique of choice considering its historical background and long experience worldwide. Recently however, TAVI has positioned itself as the only standard therapy for symptomatic patients who are not candidates for surgery. Aim: To report the experience with this new technique comparing our results with those reported in the literature. Material and Methods: Between May 2010 and December 2011,17patients aged 81 ± 7.3 years (58.8% men with an Euro SCORE 29 ± 22.4%) underwent a TAVI. Results: The median transvalvular gradient was 54 ± 15.7 mmHg. All patients received a CoreValveTM. Technical success was 100%, with a post implant gradient of 6.29 ± 3.3 mmHg. Residual aortic regurgita-tion was observed in 94%, none greater than grade II. There were no complications at the vascular access site. One patient developed cardiac tamponade during the procedure. Permanent pacemaker implantation was required in 35.2%. Hospital mortality rate was 5.8%, a figure that remained unchanged at 30 days offollow-up. Conclusions: In high-risk patients with aortic stenosis, TAVI has a high success rate and a low rate of complications. Besides an appropriate patient selection, a trained multidisciplinary team and technical conditions to solve possible complications of the procedure are required.info:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.141 n.1 20132013-01-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872013000100001es10.4067/S0034-98872013000100001 |
institution |
Scielo Chile |
collection |
Scielo Chile |
language |
Spanish / Castilian |
topic |
Aortic valve replacement Aortic valve stenosis Balloon valvuloplasty |
spellingShingle |
Aortic valve replacement Aortic valve stenosis Balloon valvuloplasty Caorsi,Carlos Baeza,Cristian Morís,César Oyonarte,Miguel Venegas,Juan Carlos Yovanovich,Jorge Rufs,Jorge Díaz,Rodrigo Espíndola,Manuel Implante valvular aórtico transarterial: experiencia en Chile |
description |
Background: Transcatheter aortic valve implantation (TAVI) is taking a leading role in the management of patients with severe aortic stenosis. Valve replacement surgery prolongs survival and is the technique of choice considering its historical background and long experience worldwide. Recently however, TAVI has positioned itself as the only standard therapy for symptomatic patients who are not candidates for surgery. Aim: To report the experience with this new technique comparing our results with those reported in the literature. Material and Methods: Between May 2010 and December 2011,17patients aged 81 ± 7.3 years (58.8% men with an Euro SCORE 29 ± 22.4%) underwent a TAVI. Results: The median transvalvular gradient was 54 ± 15.7 mmHg. All patients received a CoreValveTM. Technical success was 100%, with a post implant gradient of 6.29 ± 3.3 mmHg. Residual aortic regurgita-tion was observed in 94%, none greater than grade II. There were no complications at the vascular access site. One patient developed cardiac tamponade during the procedure. Permanent pacemaker implantation was required in 35.2%. Hospital mortality rate was 5.8%, a figure that remained unchanged at 30 days offollow-up. Conclusions: In high-risk patients with aortic stenosis, TAVI has a high success rate and a low rate of complications. Besides an appropriate patient selection, a trained multidisciplinary team and technical conditions to solve possible complications of the procedure are required. |
author |
Caorsi,Carlos Baeza,Cristian Morís,César Oyonarte,Miguel Venegas,Juan Carlos Yovanovich,Jorge Rufs,Jorge Díaz,Rodrigo Espíndola,Manuel |
author_facet |
Caorsi,Carlos Baeza,Cristian Morís,César Oyonarte,Miguel Venegas,Juan Carlos Yovanovich,Jorge Rufs,Jorge Díaz,Rodrigo Espíndola,Manuel |
author_sort |
Caorsi,Carlos |
title |
Implante valvular aórtico transarterial: experiencia en Chile |
title_short |
Implante valvular aórtico transarterial: experiencia en Chile |
title_full |
Implante valvular aórtico transarterial: experiencia en Chile |
title_fullStr |
Implante valvular aórtico transarterial: experiencia en Chile |
title_full_unstemmed |
Implante valvular aórtico transarterial: experiencia en Chile |
title_sort |
implante valvular aórtico transarterial: experiencia en chile |
publisher |
Sociedad Médica de Santiago |
publishDate |
2013 |
url |
http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872013000100001 |
work_keys_str_mv |
AT caorsicarlos implantevalvularaorticotransarterialexperienciaenchile AT baezacristian implantevalvularaorticotransarterialexperienciaenchile AT moriscesar implantevalvularaorticotransarterialexperienciaenchile AT oyonartemiguel implantevalvularaorticotransarterialexperienciaenchile AT venegasjuancarlos implantevalvularaorticotransarterialexperienciaenchile AT yovanovichjorge implantevalvularaorticotransarterialexperienciaenchile AT rufsjorge implantevalvularaorticotransarterialexperienciaenchile AT diazrodrigo implantevalvularaorticotransarterialexperienciaenchile AT espindolamanuel implantevalvularaorticotransarterialexperienciaenchile |
_version_ |
1718436667635793920 |